Blog

New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
Benefits of Working with a CDMO

Benefits of Working with a CDMO

The combined small and large molecule Contract Development and Manufacturing Organization (CDMO) market was valued at $52.8 billion dollars in 2021 with annual growth rates of 6.5% and 8.6% (respectively) from 2022 to 2030.  So, why are more and more biotech and...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
New Publications Review: Medicinal and Organic Chemistry

New Publications Review: Medicinal and Organic Chemistry

This blog series presents links to new literature on topics of Medicinal and Organic Chemistry. It is derived from surveys of the Table of Contents for the Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Organic Chemistry, Journal of the...

read more
Happy Mid-Autumn Festival

Happy Mid-Autumn Festival

With popularity on par with Chinese New Year, the Mid-Autumn Festival is one of the most important holidays in Chinese culture and is celebrated all over the world during the full moon between September and October. Festival Origin Over 3,000 years ago, during the...

read more
Employee Spotlight: Dr. Lilly Xu

Employee Spotlight: Dr. Lilly Xu

Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Dr. Lilly Xu Dr. Lilly Xu SVP and Head of DMPK and Exploratory Toxicology at ChemPartner Q&A with Dr. Xu How long have you been with...

read more
Antibody Generation: Single B Cell Cloning vs. Hybridoma

Antibody Generation: Single B Cell Cloning vs. Hybridoma

PD-L1 is a key inhibitor of T cell activation that is often over-expressed in cancer to escape immune surveillance and promote tumor progression. Blocking antibodies against PD-L1 or its receptor, PD-1, have shown significant clinical benefit in some patients with...

read more
How Is Remdesivir Made?

How Is Remdesivir Made?

Gileadʹs antiviral drug remdesivir (Veklury, 1) was approved by the FDA on May 1st for emergency use against coronavirus disease-2019 (COVID-19) after just a one-day review. Now the onerous task falls upon Gilead to make enough of the drug to supply doctors and...

read more
p

Resources

Careers
Services
Publications
Resources
Contact
Privacy Policy

Headquarters

1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203

w

Contact Us

China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000
Japan: +81 03 5403 6975

contact@chempartner.com